106 related articles for article (PubMed ID: 22022468)
1. Epigenetic control of viral life-cycle by a DNA-methylation dependent transcription factor.
Flower K; Thomas D; Heather J; Ramasubramanyan S; Jones S; Sinclair AJ
PLoS One; 2011; 6(10):e25922. PubMed ID: 22022468
[TBL] [Abstract][Full Text] [Related]
2. The effects of cytosine methylation on general transcription factors.
Jin J; Lian T; Gu C; Yu K; Gao YQ; Su XD
Sci Rep; 2016 Jul; 6():29119. PubMed ID: 27385050
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide quantification of the effects of DNA methylation on human gene regulation.
Lea AJ; Vockley CM; Johnston RA; Del Carpio CA; Barreiro LB; Reddy TE; Tung J
Elife; 2018 Dec; 7():. PubMed ID: 30575519
[TBL] [Abstract][Full Text] [Related]
4. Single molecule characterization of the binding kinetics of a transcription factor and its modulation by DNA sequence and methylation.
Khamis H; Rudnizky S; Melamed P; Kaplan A
Nucleic Acids Res; 2021 Nov; 49(19):10975-10987. PubMed ID: 34606618
[TBL] [Abstract][Full Text] [Related]
5. Using methylation data to improve transcription factor binding prediction.
Morgan D; DeMeo DL; Glass K
Epigenetics; 2024 Dec; 19(1):2309826. PubMed ID: 38300850
[TBL] [Abstract][Full Text] [Related]
6. Modeling methyl-sensitive transcription factor motifs with an expanded epigenetic alphabet.
Viner C; Ishak CA; Johnson J; Walker NJ; Shi H; Sjöberg-Herrera MK; Shen SY; Lardo SM; Adams DJ; Ferguson-Smith AC; De Carvalho DD; Hainer SJ; Bailey TL; Hoffman MM
Genome Biol; 2024 Jan; 25(1):11. PubMed ID: 38191487
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Viruses and the Epigenome: How Viruses Hijack Epigenetic Mechanisms to Drive Cancer.
MacLennan SA; Marra MA
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298494
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of DNA methylation-dependent site selectivity of the Epstein-Barr virus lytic switch protein ZEBRA/Zta/BZLF1.
Bernaudat F; Gustems M; Günther J; Oliva MF; Buschle A; Göbel C; Pagniez P; Lupo J; Signor L; Müller CW; Morand P; Sattler M; Hammerschmidt W; Petosa C
Nucleic Acids Res; 2022 Jan; 50(1):490-511. PubMed ID: 34893887
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.
Ruiz-Pablos M; Paiva B; Montero-Mateo R; Garcia N; Zabaleta A
Front Immunol; 2021; 12():656797. PubMed ID: 34867935
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin Resistance in Epstein-Barr-Virus-Associated Gastric Carcinoma Acquired through
Lee SH; Choi SJ; Choi W; Cho S; Cho M; Kim DS; Kang BW; Kim JG; Lee YM; Cho H; Kang H
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503060
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation.
Buschle A; Mrozek-Gorska P; Cernilogar FM; Ettinger A; Pich D; Krebs S; Mocanu B; Blum H; Schotta G; Straub T; Hammerschmidt W
Nucleic Acids Res; 2021 Apr; 49(6):3217-3241. PubMed ID: 33675667
[TBL] [Abstract][Full Text] [Related]
12. Role of DNA Methylation and CpG Sites in the Viral Telomerase RNA Promoter during Gallid Herpesvirus 2 Pathogenesis.
Pejaković S; Mbouombouo Mfossa AC; Wiggers L; Kheimar A; Coupeau D; Kaufer BB; Muylkens B
J Virol; 2020 Nov; 94(23):. PubMed ID: 32967954
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Properties of the EBV ZEBRA Protein.
Germini D; Sall FB; Shmakova A; Wiels J; Dokudovskaya S; Drouet E; Vassetzky Y
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517128
[TBL] [Abstract][Full Text] [Related]
14. A Noncanonical Basic Motif of Epstein-Barr Virus ZEBRA Protein Facilitates Recognition of Methylated DNA, High-Affinity DNA Binding, and Lytic Activation.
Weber E; Buzovetsky O; Heston L; Yu KP; Knecht KM; El-Guindy A; Miller G; Xiong Y
J Virol; 2019 Jul; 93(14):. PubMed ID: 31068430
[TBL] [Abstract][Full Text] [Related]
15. BZLF1 interacts with chromatin remodelers promoting escape from latent infections with EBV.
Schaeffner M; Mrozek-Gorska P; Buschle A; Woellmer A; Tagawa T; Cernilogar FM; Schotta G; Krietenstein N; Lieleg C; Korber P; Hammerschmidt W
Life Sci Alliance; 2019 Apr; 2(2):. PubMed ID: 30926617
[TBL] [Abstract][Full Text] [Related]
16. Replacing C189 in the bZIP domain of Zta with S, T, V, or A changes DNA binding specificity to four types of double-stranded DNA.
Ray S; Tillo D; Assad N; Ufot A; Deppmann C; Durell SR; Porollo A; Vinson C
Biochem Biophys Res Commun; 2018 Jul; 501(4):905-912. PubMed ID: 29772230
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta.
Almohammed R; Osborn K; Ramasubramanyan S; Perez-Fernandez IBN; Godfrey A; Mancini EJ; Sinclair AJ
J Gen Virol; 2018 Jun; 99(6):805-817. PubMed ID: 29580369
[TBL] [Abstract][Full Text] [Related]
18. The Epstein-Barr Virus B-ZIP Protein Zta Recognizes Specific DNA Sequences Containing 5-Methylcytosine and 5-Hydroxymethylcytosine.
Tillo D; Ray S; Syed KS; Gaylor MR; He X; Wang J; Assad N; Durell SR; Porollo A; Weirauch MT; Vinson C
Biochemistry; 2017 Nov; 56(47):6200-6210. PubMed ID: 29072898
[TBL] [Abstract][Full Text] [Related]
19. PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter.
Lupey-Green LN; Moquin SA; Martin KA; McDevitt SM; Hulse M; Caruso LB; Pomerantz RT; Miranda JL; Tempera I
Virology; 2017 Jul; 507():220-230. PubMed ID: 28456021
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis.
Li H; Liu S; Hu J; Luo X; Li N; M Bode A; Cao Y
Int J Biol Sci; 2016; 12(11):1309-1318. PubMed ID: 27877083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
